Effect of a serotonin receptor antagonist on interleukin-6-induced pulmonary hypertension in rats

被引:41
|
作者
Miyata, M [1 ]
Ito, M [1 ]
Sasajima, T [1 ]
Ohira, H [1 ]
Kasukawa, R [1 ]
机构
[1] Fukushima Med Univ, Sch Med, Dept Internal Med 2, Fukushima, Japan
关键词
5-hydroxytryptamine; interleukin; 6; MCI-90-42; pulmonary hypertension; serotonin; serotonin receptor; serotonin receptor antagonist; thromboembolic pulmonary hypertension;
D O I
10.1378/chest.119.2.554
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: To determine the significance of serotonin in the pathogenesis of interleukin (IL) 6-induced pulmonary hypertension (IL-6-PH) in rats, the plasma serotonin concentrations, and the effects of a specific antagonist of the serotonin (5-hydroxytryptamine [5-HT]) receptor, 1-[o-(m-methoxyphenyl)ethyl]phenoxy]-3-(dimethylamino)-2-propyl hydrogen succinate hydrochloride (MCI) on the degree of pulmonary hypertension (PH) were investigated in MCI-treated IL-6-PH (IL-6-MCI-PH) rats. Measurements: The thickness of the media of small pulmonary arteries and the ratio of the weight of the right ventricle free wall (RV) to that of the left ventricle with the septum (LV + S) were measured as indexes of the degree of PH. Serotonin concentrations in plasma and in supernatants of cultured vascular smooth muscle cells (VSMCs) stimulated by IL-6 were measured by high-performance liquid chromatography. The amplification of DNA encoding the 5-HT receptor in the lung specimen and VSMCs was performed by polymerase chain reaction. Results: The degree of PH, as determined by the medial thickness of small pulmonary arteries, was significantly increased in IL-6-PH rats as compared with normal control rats (p < 0.05), and that in IL-6-MCI-PH rats was not significantly different from that in normal control rats. The RV/LV + S weight ratio in the IL-6-PH rats was significantly higher than that in normal control rats (p < 0.01). The RV/LV + S weight ratio in IL-6-MCI-PH rats was significantly lower than that in IL-6-PH rats (p < 0.01) and was not significantly different from that in normal control rats. The serotonin concentration was significantly higher in IL-6-PH rats than in normal control rats (p < 0.02), and the serotonin concentration in IL-6-MCI-PH rats was not significantly different from that in the normal control rats. The expression levels of the 5-HT receptor messenger RNA in the lung tissue tended to increase in IL-6-PH rats but was suppressed in IL-6-MCI-PH rats. IL-6 significantly increased the amount of serotonin released from VSMCs (p < 0.02). The expression of the 5-HT receptor messenger RNA was observed with IL-6 stimulation as was observed with serotonin stimulation in VSMCs. Conclusions: Serotonin receptor antagonists could be considered as potentially useful agents for the treatment of chronic thromboembolic PH, as well as for that of primary PH and PH associated with collagen vascular diseases.
引用
收藏
页码:554 / 561
页数:8
相关论文
共 50 条
  • [1] Serotonin receptor antagonist inhibits monocrotaline-induced pulmonary hypertension and prolongs survival in rats
    Hironaka, E
    Hongo, M
    Sakai, A
    Mawatari, E
    Terasawa, F
    Okumura, N
    Yamazaki, A
    Ushiyama, Y
    Yazaki, Y
    Kinoshita, O
    CARDIOVASCULAR RESEARCH, 2003, 60 (03) : 692 - 699
  • [2] Development of monocrotaline-induced pulmonary hypertension is attenuated by a serotonin receptor antagonist
    Miyata, M
    Ito, M
    Sasajima, T
    Ohira, H
    Sato, Y
    Kasukawa, R
    LUNG, 2000, 178 (02) : 63 - 73
  • [3] Development of Monocrotaline-Induced Pulmonary Hypertension Is Attenuated by a Serotonin Receptor Antagonist
    M. Miyata
    M. Ito
    T. Sasajima
    H. Ohira
    Y. Sato
    R. Kasukawa
    Lung, 2000, 178 : 63 - 73
  • [4] Antagonism effects of cypermethrin on interleukin-6-induced androgen receptor activation
    Wang, Qi
    Xu, Li-Fang
    Zhou, Ji-Long
    Zhou, Xiao-Long
    Wang, Hui
    Ju, Qiang
    Pan, Chen
    Zhang, Jin-Peng
    Zhang, Mei-Rong
    Yu, Hong-Min
    Xu, Li-Chun
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2015, 40 (01) : 172 - 174
  • [5] INTERLEUKIN-1 RECEPTOR ANTAGONIST INHIBITS PULMONARY-HYPERTENSION INDUCED BY INFLAMMATION
    VOELKEL, NF
    TUDER, R
    CELLS AND CYTOKINES IN LUNG INFLAMMATION, 1994, 725 : 104 - 109
  • [6] Beneficial effect of the AT1 receptor antagonist olmesartan on monocrotaline-induced pulmonary hypertension in rats
    Kato, T
    Ikeda, M
    Ito, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 182P - 182P
  • [7] The Protective Effect of The Interleukin 1 Receptor Antagonist on Chronic Thromboembolic Pulmonary Hypertension Model
    Kalemci, Serdar
    Zeybek, Arife
    Micili, Serap Cilaker
    Sarihan, Aydin
    Calisir, Meryem
    Simsek, Abdullah
    Akin, Fatih
    Ihtiyar, Alperen
    Yilmaz, Osman
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2019, 73 : 944 - 950
  • [8] A soluble interleukin-6 receptor mutant inhibits interleukin-6-induced signal transduction in myeloma cells
    Lun Song
    Beifen Shen
    Yunfang Ren
    Biotechnology Letters, 2002, 24 : 1243 - 1248
  • [9] A soluble interleukin-6 receptor mutant inhibits interleukin-6-induced signal transduction in myeloma cells
    Song, L
    Shen, BF
    Ren, YF
    BIOTECHNOLOGY LETTERS, 2002, 24 (15) : 1243 - 1248
  • [10] INTERLEUKIN-1 RECEPTOR ANTAGONIST TREATMENT REDUCES PULMONARY-HYPERTENSION GENERATED IN RATS BY MONOCROTALINE
    VOELKEL, NF
    TUDER, RM
    BRIDGES, J
    AREND, WP
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 11 (06) : 664 - 675